Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Metastatic Non-small Cell Lung Cancer × Zoledronic Acid × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 7 Small Cell Lung Carcinoma 2 Pleural Effusion, Malignant 2 Neoplasm Metastasis 2 Prostatic Neoplasms 1 Pain 1 Mesothelioma 1 Humoral Hypercalcemia Of Malignancy 1 Breast Neoplasms 1 Bone Metastatic Non-small Cell Lung Cancer 1

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04325776 2020-10-12

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Unknown

Bone Metastatic Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡